Home › NDC Lookup › RxCUI directory › RxCUI 1010673

Lidocaine hydrochloride 20 MG/ML Injectable Solution [Xylocaine] — RxCUI 1010673

RxNorm drug concept · Semantic branded drug
RxCUI 1010673 Semantic branded drug · SBD ● Current RxNorm concept 20 FDA products 39 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI1010673
Official nameLidocaine hydrochloride 20 MG/ML Injectable Solution [Xylocaine]
Concept typeSemantic branded drug (SBD)
RxNorm statusCurrent RxNorm concept
Also known asXylocaine 2 % Injectable Solution; Xylocaine 20 MG/ML Injectable Solution
FDA products mapped20
Package NDCs mapped39
Reported Medicaid activity (SDUD)115,224 prescriptions · 42 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Lidocaine Transdermal Patch: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • It relieves nerve pain from post-herpetic neuralgia, the lingering pain that can follow shingles. It is used in adults. It numbs the pain signals in the skin under the patch.
  • Usually up to 12 hours in a 24-hour period, then 12 hours off. Put it on intact skin over the most painful spot. Do not use more patches than prescribed.
  • No. Heat can increase how much lidocaine gets absorbed. With Ztlido, you can apply a patch after brief heat, but never put a heating pad or electric blanket directly on it.
  • For Ztlido, light exercise and short water exposure, like a 10-minute shower, are okay. Gently pat it dry rather than rubbing. If the edges lift, press them down.
📖 Read our full Lidocaine Transdermal Patch guide →

🕸️ Concept Web — How Lidocaine hydrochloride 20 MG/ML Injectable Solu... Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Lidocaine hydrochloride 20 MG/ML Injectable Solution [Xylocaine] RxCUI 1010673

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 2

    The active substance itself — no strength, form, or brand attached yet.

    • Lidocaine 6387
    • Lidocaine hydrochloride 142440
  2. Brand names 1

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • Xylocaine 202398
  3. Dose forms 9

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Lidocaine Injectable Solution 372599
    • Lidocaine hydrochloride Injectable Solution 2645415
    • Lidocaine Injectable Product 1164658
    • Lidocaine hydrochloride Injectable Product 2663499
    • Lidocaine Injectable Solution [Xylocaine] 94618
    • Lidocaine hydrochloride Injectable Solution [Xylocaine] 2655953
    • Xylocaine Injectable Product 1186620
    • Injectable Solution 316949
    • +1 more in this family
  4. Clinical & branded drugs 3

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

Showing up to 8 concepts per family — 14 of 15 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Lidocaine hydrochloride 20 MG/ML Injectable Solution SCD · 1010671
  • Lidocaine hydrochloride 20 MG/ML SCDC · 1010670
  • Lidocaine Injectable Solution SCDF · 372599
  • Lidocaine hydrochloride Injectable Solution SCDFP · 2645415
  • Lidocaine Injectable Product SCDG · 1164658
  • Lidocaine hydrochloride Injectable Product SCDGP · 2663499

Brand-Name Concepts

  • Lidocaine hydrochloride 20 MG/ML [Xylocaine] SBDC · 1010672
  • Lidocaine Injectable Solution [Xylocaine] SBDF · 94618
  • Lidocaine hydrochloride Injectable Solution [Xylocaine] SBDFP · 2655953
  • Xylocaine Injectable Product SBDG · 1186620
  • Xylocaine BN · 202398

📦 FDA Products & Package NDCs

20 products · 39 package NDCs
39 package NDCs map to RxCUI 1010673 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
00404-9974-20 1 VIAL in 1 BAG (0404-9974-20) / 20 mL in 1 VIAL Xylocaine Henry Schein, Inc. 2022-01-17
00404-9974-50 1 VIAL in 1 BAG (0404-9974-50) / 50 mL in 1 VIAL Xylocaine Henry Schein, Inc. 2022-01-17
63323-0481-57 25 VIAL, MULTI-DOSE in 1 TRAY (63323-481-57) / 50 mL in 1 V... Xylocaine Fresenius Kabi USA, LLC 2010-08-12
63323-0482-17 25 VIAL, MULTI-DOSE in 1 TRAY (63323-482-17) / 10 mL in 1 V... Xylocaine Fresenius Kabi USA, LLC 2010-08-12
63323-0482-26 25 VIAL, MULTI-DOSE in 1 TRAY (63323-482-26) / 20 mL in 1 V... Xylocaine Fresenius Kabi USA, LLC 2010-08-12
63323-0482-27 25 VIAL, MULTI-DOSE in 1 TRAY (63323-482-27) / 20 mL in 1 V... Xylocaine Fresenius Kabi USA, LLC 2010-08-12
63323-0482-57 25 VIAL, MULTI-DOSE in 1 TRAY (63323-482-57) / 50 mL in 1 V... Xylocaine Fresenius Kabi USA, LLC 2010-08-12
63323-0483-27 25 VIAL, MULTI-DOSE in 1 TRAY (63323-483-27) / 20 mL in 1 V... Xylocaine Fresenius Kabi USA, LLC 2010-08-12
63323-0483-57 25 VIAL, MULTI-DOSE in 1 TRAY (63323-483-57) / 50 mL in 1 V... Xylocaine Fresenius Kabi USA, LLC 2010-08-12
63323-0484-57 25 VIAL, MULTI-DOSE in 1 TRAY (63323-484-57) / 50 mL in 1 V... Xylocaine Fresenius Kabi USA, LLC 2010-08-12
63323-0485-26 25 VIAL, MULTI-DOSE in 1 TRAY (63323-485-26) / 20 mL in 1 V... Xylocaine Fresenius Kabi USA, LLC 2010-08-12
63323-0485-27 25 VIAL, MULTI-DOSE in 1 TRAY (63323-485-27) / 20 mL in 1 V... Xylocaine Fresenius Kabi USA, LLC 2010-08-12
63323-0485-57 25 VIAL, MULTI-DOSE in 1 TRAY (63323-485-57) / 50 mL in 1 V... Xylocaine Fresenius Kabi USA, LLC 2010-08-12
63323-0486-17 25 VIAL, MULTI-DOSE in 1 TRAY (63323-486-17) / 10 mL in 1 V... Xylocaine Fresenius Kabi USA, LLC 2010-08-12
63323-0486-26 25 VIAL, MULTI-DOSE in 1 TRAY (63323-486-26) / 20 mL in 1 V... Xylocaine Fresenius Kabi USA, LLC 2010-08-12
63323-0486-27 25 VIAL, MULTI-DOSE in 1 TRAY (63323-486-27) / 20 mL in 1 V... Xylocaine Fresenius Kabi USA, LLC 2010-08-12
63323-0486-57 25 VIAL, MULTI-DOSE in 1 TRAY (63323-486-57) / 50 mL in 1 V... Xylocaine Fresenius Kabi USA, LLC 2010-08-12
63323-0487-17 25 VIAL, SINGLE-DOSE in 1 TRAY (63323-487-17) / 10 mL in 1... Xylocaine MPF Fresenius Kabi USA, LLC 2010-08-12
63323-0487-31 5 VIAL, SINGLE-DOSE in 1 CARTON (63323-487-31) / 30 mL in 1... Xylocaine MPF Fresenius Kabi USA, LLC 2010-08-12
63323-0487-37 25 VIAL, SINGLE-DOSE in 1 TRAY (63323-487-37) / 30 mL in 1... Xylocaine MPF Fresenius Kabi USA, LLC 2010-08-12
63323-0488-17 25 VIAL, SINGLE-DOSE in 1 TRAY (63323-488-17) / 10 mL in 1... Xylocaine MPF Fresenius Kabi USA, LLC 2010-08-12
63323-0488-31 5 VIAL, SINGLE-DOSE in 1 CARTON (63323-488-31) / 30 mL in 1... Xylocaine MPF Fresenius Kabi USA, LLC 2010-08-12
63323-0488-37 25 VIAL, SINGLE-DOSE in 1 TRAY (63323-488-37) / 30 mL in 1... Xylocaine MPF Fresenius Kabi USA, LLC 2010-08-12
63323-0489-17 25 VIAL, SINGLE-DOSE in 1 TRAY (63323-489-17) / 10 mL in 1... Xylocaine MPF Fresenius Kabi USA, LLC 2010-08-12
63323-0489-21 5 VIAL, SINGLE-DOSE in 1 CARTON (63323-489-21) / 20 mL in 1... Xylocaine MPF Fresenius Kabi USA, LLC 2010-08-12
63323-0489-27 25 VIAL, SINGLE-DOSE in 1 TRAY (63323-489-27) / 20 mL in 1... Xylocaine MPF Fresenius Kabi USA, LLC 2010-08-12
63323-0491-57 25 VIAL, SINGLE-DOSE in 1 TRAY (63323-491-57) / 50 mL in 1... Xylocaine MPF Fresenius Kabi USA, LLC 2010-08-12
63323-0492-16 25 VIAL, SINGLE-DOSE in 1 CARTON (63323-492-16) / 2 mL in 1... Xylocaine MPF Fresenius Kabi USA, LLC 2010-08-12
63323-0492-26 25 VIAL, SINGLE-DOSE in 1 TRAY (63323-492-26) / 30 mL in 1... Xylocaine MPF Fresenius Kabi USA, LLC 2010-08-12
63323-0492-27 25 VIAL, SINGLE-DOSE in 1 CARTON (63323-492-27) / 2 mL in 1... Xylocaine MPF Fresenius Kabi USA, LLC 2010-08-12
63323-0492-31 5 VIAL, SINGLE-DOSE in 1 CARTON (63323-492-31) / 30 mL in 1... Xylocaine MPF Fresenius Kabi USA, LLC 2010-08-12
63323-0492-36 25 VIAL, SINGLE-DOSE in 1 CARTON (63323-492-36) / 5 mL in 1... Xylocaine MPF Fresenius Kabi USA, LLC 2010-08-12
63323-0492-37 25 VIAL, SINGLE-DOSE in 1 TRAY (63323-492-37) / 30 mL in 1... Xylocaine MPF Fresenius Kabi USA, LLC 2010-08-12
63323-0492-57 25 VIAL, SINGLE-DOSE in 1 CARTON (63323-492-57) / 5 mL in 1... Xylocaine MPF Fresenius Kabi USA, LLC 2010-08-12
63323-0495-07 25 VIAL, SINGLE-DOSE in 1 CARTON (63323-495-07) / 5 mL in 1... Xylocaine MPF Fresenius Kabi USA, LLC 2010-08-12
63323-0495-26 25 VIAL, SINGLE-DOSE in 1 CARTON (63323-495-26) / 5 mL in 1... Xylocaine MPF Fresenius Kabi USA, LLC 2010-08-12
63323-0495-27 25 VIAL, SINGLE-DOSE in 1 CARTON (63323-495-27) / 2 mL in 1... Xylocaine MPF Fresenius Kabi USA, LLC 2010-08-12
76420-0369-25 25 VIAL, MULTI-DOSE in 1 TRAY (76420-369-25) / 10 mL in 1 V... Xylocaine Asclemed USA, Inc. 2025-05-31
85766-0018-10 10 mL in 1 VIAL, MULTI-DOSE (85766-018-10) Xylocaine Sportpharm LLC 2025-06-20
Observed labelers: Fresenius Kabi USA, LLC (35) · Henry Schein, Inc. (2) · Asclemed USA, Inc. (1) · Sportpharm LLC (1) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.